Insomnia Therapy Market was valued at USD 4.5 Billion in 2022 and is projected to reach USD 9.4 Billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030.
In the years between 2018 and 2022, the insomnia therapy market was dominated by drug-based treatments such as sedative-hypnotics, benzodiazepines, and new-generation sleep aids. However, cognitive behavioral therapy (CBT) and digital therapeutics also gained significant momentum due to their non-invasive nature and long-lasting effects. By 2022, the market had seen the advent of a variety of digital solutions, including sleep apps and online therapy programs, offering affordable and easily accessible treatments. These options attracted a tech-savvy consumer base looking for personalized and convenient insomnia management solutions.
Looking forward, from 2023 to 2033, the demand for insomnia therapies is expected to escalate further due to changing lifestyle trends, an increase in mental health awareness, and the growing adoption of digital health tools. Additionally, factors such as the aging population and the rise in chronic conditions contributing to sleep disturbances will drive demand for new and improved therapies. The rise in personalized medicine and AI-driven treatment plans will further augment market growth. In particular, the demand for non-pharmacological treatments like CBT-i (Cognitive Behavioral Therapy for Insomnia) and virtual therapy solutions is expected to rise sharply as people seek more sustainable, holistic treatments.
The future of insomnia therapy lies in improving accessibility and affordability, as the market is now trending toward a more consumer-centric approach. As digital and telemedicine solutions continue to evolve, patients are likely to have greater access to therapies that better fit their individual needs. This shift will likely accelerate the market growth in the next decade, as more people embrace both traditional and innovative forms of treatment.
Get an In-Depth Research Analysis of the Global Insomnia Therapy Market Size And Forecast [2025-2032]
The global insomnia therapy market has witnessed significant growth from 2018 to 2022. During this period, increasing awareness about sleep disorders, along with advancements in therapeutic options, played a vital role in driving market growth. The market for insomnia therapies is primarily driven by the rising prevalence of insomnia, which has been compounded by modern-day stressors and lifestyle factors. An estimated 10-30% of adults globally suffer from some form of insomnia, leading to an increased demand for effective treatments. Moreover, the market has been shaped by innovations in pharmacological treatments, cognitive-behavioral therapy, and emerging natural remedies.
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai
Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Insomnia Therapy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Insomnia Therapy Market
Hospital
Ambulatory Surgical Center
Home Care
Based on Types the Market is categorized into Below types that held the largest Insomnia Therapy market share In 2023.
Non-pharmacological Therapy
Pharmacological Therapy
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Insomnia Therapy Market Research Analysis
1. Introduction of the Global Insomnia Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Insomnia Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Insomnia Therapy Market, By Type
6. Global Insomnia Therapy Market, By Application
7. Global Insomnia Therapy Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Insomnia Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/